VolitionRX (NYSEAMERICAN:VNRX) Stock Crosses Below 50 Day Moving Average – Should You Sell?

VolitionRX Limited (NYSEAMERICAN:VNRX) shares passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.28 and traded as low as $0.2203. VolitionRX shares last traded at $0.2241, with a volume of 2,703,582 shares.

VolitionRX Trading Down 8.5%

The firm has a market cap of $30.09 million, a PE ratio of -0.97 and a beta of 1.29. The company has a 50-day simple moving average of $0.28 and a 200 day simple moving average of $0.45.

VolitionRX Company Profile

VolitionRX, traded as VNRX on the NYSE American exchange, is a pioneering life sciences company focused on the development and commercialization of minimally invasive diagnostic tests for the early detection of cancer and other diseases. Utilizing proprietary technology to analyze circulating nucleosomes in blood samples, the company’s platform identifies disease-specific epigenetic and biochemical signatures. By offering blood-based screening solutions, VolitionRX aims to deliver alternatives to invasive, costly and time-consuming procedures, potentially improving patient outcomes through earlier diagnosis.

The company’s flagship product suite, branded as Nu.Q, comprises assays designed to detect biomarkers associated with a range of malignancies, including colorectal, lung and pancreatic cancers, as well as other systemic conditions.